GlassScriptPhysician profile
Brian S Anderson
NPI 1447231816
$4,046.95
in general payments reported to CMS, 2019-2025
39 companies · $840 in 2025
The $840 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $268 · 2021: $714 · 2022: $632 · 2023: $457 · 2024: $578 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,874.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $680.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $486.05 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $327.15 | 2019-2024 | Prolia, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $304.41 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $254.95 | 2019-2025 | |
| Pfizer INC. | $209.69 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $190.92 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.66 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $155.96 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.16 | 2020-2024 | Xifaxan |
| Abbvie INC. | $125.28 | 2022-2024 | Dalvance |
| Takeda Pharmaceuticals U.S.A., INC. | $116.05 | 2021-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $109.11 | 2021-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Eisai INC. | $85.68 | 2021-2022 | |
| Boston Scientific Corporation | $68.87 | 2025 | General - Pain Management |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.